Curis Lifecare

Curis Lifecare Curis Lifecare is a pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages medicines.

Curis Lifecare is a pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Combined with our strong commitment to supply high quality products and our dedication to research and develop new products that will greatly improve the health and wellness, Curis has created a reputation as being forward-thinking and an innovative pharmaceutical company. We aspire to stay agile year after year, creating a vision driven organization that continuously strives to empower its stakeholders with integrity, ethics and trust. Committed to patient care since inception, our focus on specialty segments in India and simultaneous opening of new international markets has been accelerating our growth over the years. In India, we have significant presence in the fast growing specialty therapeutic segments of Cardiovascular, Respiratory, Neurology, Dermatology, Ophthalmology and many more. We are fully committed to focus on the needs of our customers with a strategy that allows us to develop, produce and market high quality medications. With primary focus on new product innovation and introduction, we have been consistently identifying unmet medical needs and introducing newer products to cater to those needs. Our products provide patient compliance and convenience over existing therapeutic options. A culture of innovation is as much one of the Company‘s core values as is acting according to ethical principles with respect to staff, partners, and the environment. Since its inception Curis aspires to be customer-centric and a leader in the Indian markets. Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare. Our unique assets and skills are always oriented towards developing novel and differentiating scientific solutions through innovative products designed to improve the quality of life. It is a remarkable collection of dynamic and innovative people dedicated to the constant pursuit of excellence who keep the deserved reputation of Curis intact for unparalleled quality, service and value.

31/08/2026
*🎯 Jangolia GM 2/1000 - Combined Clinical USP*✅ Comprehensive Glycemic Coveragefasting + PP sugar + HbA1c control✅ Lower...
19/05/2026

*🎯 Jangolia GM 2/1000 - Combined Clinical USP*

✅ Comprehensive Glycemic Coverage
fasting + PP sugar + HbA1c control

✅ Lower Pill Burden
3 mechanisms in single tablet
improves compliance

✅ Better Long-Term Glycemic Stability

✅ Weight Neutral Advantage

✅ Useful in Patients with:
uncontrolled HbA1c
overweight
insulin resistance
high PP sugar spikes

*Maker of Jangolia GM 2*

*🎯 FUROSIS 200/400 - CORE USP 🎯**🔬“Dual Action Therapy – Rapid Bronchodilation + Long-Term Inflammation Control”**⚡ 1. F...
25/04/2026

*🎯 FUROSIS 200/400 - CORE USP 🎯*

*🔬“Dual Action Therapy – Rapid Bronchodilation + Long-Term Inflammation Control”*

*⚡ 1. Fast + Sustained Relief*
Formoterol → rapid onset bronchodilator (within minutes)
Long duration (~12 hours)
👉 Gives quick symptom relief + prolonged control
*🛡 2. Strong Anti-Inflammatory Backbone*
Budesonide → inhaled corticosteroid
✔ Reduces airway inflammation
✔ Prevents exacerbations
*🫁 3. Complete Asthma Control*
✔ Relieves symptoms
✔ Controls underlying disease
✔ Reduces frequency of attacks
*👉 Ideal for:*
Asthma
Chronic Obstructive Pulmonary Disease
⏱ 4. Early Symptom Relief Advantage
👉 Unlike other LABA:
✔ Formoterol acts fast like a reliever
*💨 5. DPI Capsule Advantage*
✔ Breath-actuated → no coordination issue
✔ Accurate dose delivery
✔ Portable & easy to use
*🔢 6. Flexible Strength Options*
✔ Different strengths available for step-up therapy
✔ Personalized treatment
📉 7. Reduces Exacerbations & Hospitalization
✔ Proven to improve long-term outcomes
*🎯 TARGET SPECIALITY*
*Pulmonologist/ Chest PHY*
*Physician*
*Pediatrician*

Regards,
*Maker of Furosis*
*Curis Lifecare*

*💥BUDORIS 200/400 Cap - CORE USP* *👉 “Targeted Anti-Inflammatory Therapy – Directly to Lungs for Better Control with Min...
22/04/2026

*💥BUDORIS 200/400 Cap - CORE USP*

*👉 “Targeted Anti-Inflammatory Therapy – Directly to Lungs for Better Control with Minimal Systemic Effects”*

*🫁 1. Direct Lung Action (High Efficacy)*
Inhaled route → drug delivered straight to airways
✔ Faster & more effective inflammation control
*👉 Ideal for:*
Asthma
Chronic Obstructive Pulmonary Disease
*🛡 2. Minimal Systemic Side Effects*
✔ Low oral bioavailability
✔ Reduced systemic steroid exposure
👉 Safer for long-term use
*⚡ 3. Strong Anti-Inflammatory Effect*
✔ Reduces airway swelling
✔ Decreases hyper-responsiveness
👉 Prevents exacerbations
*⏱ 4. Preventive & Maintenance Therapy*
✔ Not just symptomatic relief
✔ Controls disease progression
*5. Flexible Dosing (200 & 400)*
200 mcg → mild to moderate cases
400 mcg → moderate to severe cases

*Budoris 200/400*

*🔥 KEY USPs of SULGOLIA - T**⚡ 1. Dual Mechanism for Comprehensive Control*Dapagliflozin → ↑ Urinary glucose excretion (...
07/04/2026

*🔥 KEY USPs of SULGOLIA - T*

*⚡ 1. Dual Mechanism for Comprehensive Control*
Dapagliflozin → ↑ Urinary glucose excretion (kidney pathway)
Teneligliptin → ↑ Incretin effect (pancreatic pathway)

👉 “Two complementary pathways. One powerful control.” ⭐

*🔄 2. Insulin-Independent + Insulin-Dependent Action*
Works even in insulin resistance
Enhances glucose-dependent insulin secretion

👉 “Effective across all stages of Type 2 Diabetes”

*⚖️ 3. Low Risk of Hypoglycemia*
Glucose-dependent action (Teneligliptin)
No forced insulin release

👉 “Strong control with better safety”

*⚖️ 4. Weight Reduction Benefit*
Dapagliflozin promotes calorie loss via urine

👉 “Controls sugar + supports weight loss”

*❤️ 5. Cardio-Renal Protection*
Proven benefits in:
Heart failure
Kidney protection

👉 “Beyond sugar control — organ protection” ⭐

*💧 6. Blood Pressure Reduction*
Mild diuretic effect of Dapagliflozin

👉 “Extra benefit in hypertensive diabetics”

*📉 7. Effective HbA1c Reduction*
Sustained & consistent control

👉 “Better long-term glycemic outcomes”

*💊 8. Once Daily Convenience*
Improves compliance

👉 “Simple dosing, better adherence”

*🔥 9. Ideal for Modern Diabetes Management*
Aligns with current trend:
👉 Early combination therapy + organ protection

Regards,
Maker of SULGOLIA- T
*Curis Lifecare*

*🔬TEMATEL- MCL|| Mechanism of Action  (Triple Action)*🟢 *Telmisartan → Blocks RAAS system*🟡 *Metoprolol → Controls heart...
27/02/2026

*🔬TEMATEL- MCL|| Mechanism of Action (Triple Action)*

🟢 *Telmisartan → Blocks RAAS system*
🟡 *Metoprolol → Controls heart rate & sympathetic activity*
🔵 *Cilnidipine → Reduces vascular resistance*

➡ *3 Different Pathways*
➡ *Better BP control*
➡ *Lower cardiovascular risk*

Maker of TEMATEL Group
*Curis Lifecare*

Address

Tulsyan House, 49/1, Ashwamegh Estate, Changodar
Ahmedabad
382213

Alerts

Be the first to know and let us send you an email when Curis Lifecare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Curis Lifecare:

Shortcuts

Share